Supplemental material, sj-xls-8-tct-10.1177_15330338211060202 for Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformat

DataCite Commons2024-08-28 更新70

Additional file 2: of MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study

肺癌生物标志物

肿瘤分子遗传学

The dataset supporting the conclusions of this article is available in this datasheet. (XLS 133Â kb)

Figshare2017-04-13 更新50

Supplementary Table 1: Diagnostic and economic value of biomarker testing for targetable mutations in NSCLC: a literature review

肺癌生物标志物

液体活检经济性分析

Supplementary Table 1: Embase® and MEDLINE® Search Strategy Abstract To assess the diagnostic and economic value of next-generation se-quencing (NGS) vs single-gene testing, and liquid biopsy (LBx) vs

NIAID Data Ecosystem70

Additional file 2 of Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma

顺铂耐药性

肺癌生物标志物

Supplementary Material 2. Table 2. Univariate regression analysis of cisplatin-resistance and non-resistance LUAD cohorts.

Figshare2024-08-15 更新50